تداول Eli Lilly & Co - LLY CFD
أضف إلى اللائحة المفضلة- الملخص
- بيانات الفترات السابقة
- الاحداث
- بيان الدخل
- كشف الميزانية
- التدفق النقدي
- الملكية
شروط التداول
| الفارق | 1.67 | ||||||||
|
رسوم التبييت على مركز الشراء
Long position overnight fee
الذهاب إلى المنصة | -0.030779% | ||||||||
|
رسوم التبييت على مركز البيع
Short position overnight fee
الذهاب إلى المنصة | -0.013666% | ||||||||
| اوقات رسوم التبييت | 22:00 (UTC) | ||||||||
| الحد الأدنى للكمية المتداولة | 1 | ||||||||
| العملة | USD | ||||||||
| الهامش | 20% | ||||||||
| تداول الاسهم | United States of America | ||||||||
| عمولة على التداول | 0% |
*Information provided by Capital.com
Eli Lilly and Co ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
الإحصائيات الرئيسية
| إقفال سابق* | 337.93 |
| مفتوح* | 340.19 |
| تغيير سنة* | 39.71% |
| نطاق اليوم* | 334.52 - 340.19 |
| في نطاق 52 أسبوعا | 231.87-384.44 |
| متوسط الحجم (10 أيام) | 3.98M |
| متوسط الحجم (3 أشهر) | 59.59M |
| القيمة السوقية | 322.19B |
| السهم/ربحية السهم | 49.13 |
| الأسهم القائمة | 950.18M |
| عائد | 28.54B |
| EPS | 6.90 |
| الأرباح الموزعة (الحصيلة٪) | 1.33302 |
| الإصدار التجريبي | 0.33 |
| تاريخ الأرباح القادمة | Apr 27, 2023 |
"يتم توفير جميع البيانات من قبل Refinitiv، باستثناء البيانات التي تحمل علامة النجمة، وهي * البيانات المقدمة من Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | الإغلاق | Change | Change (%) | الفتح | High | Low |
|---|---|---|---|---|---|---|
| Feb 3, 2023 | 337.93 | 5.58 | 1.68% | 332.35 | 342.09 | 328.30 |
| Feb 2, 2023 | 330.39 | -2.41 | -0.72% | 332.80 | 334.80 | 316.14 |
| Feb 1, 2023 | 342.15 | 1.23 | 0.36% | 340.92 | 345.40 | 336.80 |
| Jan 31, 2023 | 343.91 | 5.17 | 1.53% | 338.74 | 344.11 | 338.74 |
| Jan 30, 2023 | 340.18 | -1.86 | -0.54% | 342.04 | 347.28 | 339.15 |
| Jan 27, 2023 | 341.77 | -2.99 | -0.87% | 344.76 | 347.70 | 341.32 |
| Jan 26, 2023 | 347.65 | -2.14 | -0.61% | 349.79 | 351.79 | 346.30 |
| Jan 25, 2023 | 349.26 | 7.35 | 2.15% | 341.91 | 349.50 | 341.91 |
| Jan 24, 2023 | 345.92 | -16.82 | -4.64% | 362.74 | 364.89 | 339.80 |
| Jan 23, 2023 | 341.82 | -2.04 | -0.59% | 343.86 | 345.86 | 339.80 |
| Jan 20, 2023 | 345.80 | 1.01 | 0.29% | 344.79 | 348.73 | 341.12 |
| Jan 19, 2023 | 350.82 | 1.39 | 0.40% | 349.43 | 355.30 | 349.43 |
| Jan 18, 2023 | 351.45 | -4.05 | -1.14% | 355.50 | 358.73 | 351.25 |
| Jan 17, 2023 | 357.38 | -1.09 | -0.30% | 358.47 | 361.50 | 356.17 |
| Jan 13, 2023 | 361.23 | 6.08 | 1.71% | 355.15 | 362.95 | 355.15 |
| Jan 12, 2023 | 358.72 | 3.25 | 0.91% | 355.47 | 360.15 | 351.69 |
| Jan 11, 2023 | 359.86 | 7.67 | 2.18% | 352.19 | 361.49 | 348.71 |
| Jan 10, 2023 | 352.54 | 5.75 | 1.66% | 346.79 | 352.96 | 342.22 |
| Jan 9, 2023 | 349.45 | -13.34 | -3.68% | 362.79 | 364.60 | 348.43 |
| Jan 6, 2023 | 362.71 | 4.92 | 1.38% | 357.79 | 366.20 | 356.41 |
Eli Lilly & Co Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- سنوي
- فصلية
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| إجمالي الإيرادات | 21222.1 | 19973.8 | 21493.3 | 22319.5 | 24539.8 | 28318.4 |
| عائد | 21222.1 | 19973.8 | 21493.3 | 22319.5 | 24539.8 | 28318.4 |
| تكلفة الإيرادات، الإجمالي | 5654.9 | 4447.7 | 4681.7 | 4721.2 | 5483.3 | 7312.8 |
| إجمالي الربح | 15567.2 | 15526.1 | 16811.6 | 17598.3 | 19056.5 | 21005.6 |
| جمالي المصاريف التشغيلية | 17763.3 | 17970.5 | 17958.8 | 17287.9 | 18481.8 | 22366.5 |
| مصاريف البيع/النفقات العامة/الإدارية، المجموع | 6452 | 5982.4 | 5975.1 | 6213.8 | 6121.2 | 6431.6 |
| البحث والتطوير | 5243.9 | 5096.2 | 5051.2 | 5595 | 6085.7 | 7025.9 |
| مصاريف غير اعتيادية (دخل) | 412.5 | 2444.2 | 2250.8 | 757.9 | 791.6 | 1596.2 |
| الدخل التشغيلي | 3458.8 | 2003.3 | 3534.5 | 5031.6 | 6058 | 5951.9 |
| إيرادات الفوائد (المصروفات)، صافي الإيرادات غير التشغيلية | -76.5 | -58.6 | -83.2 | -320.2 | -326.6 | -137.5 |
| اخرى, صافي | -8.3 | 360.1 | 228.8 | 554.5 | 1498.5 | 341.1 |
| صافي الدخل قبل الضرائب | 3374 | 2304.8 | 3680.1 | 5265.9 | 7229.9 | 6155.5 |
| صافي الدخل بعد الضرائب | 2737.6 | 4493.6 | 3325.9 | 4637.9 | 6193.7 | 5581.7 |
| صافي الدخل قبل الإضافات. العناصر | 2737.6 | 4493.6 | 3325.9 | 4637.9 | 6193.7 | 5581.7 |
| صافي الدخل | 2737.6 | -204.1 | 3232 | 8318.4 | 6193.7 | 5581.7 |
| الدخل المتاح للمشترك باستثناء الإضافات. العناصر | 2737.6 | 4493.6 | 3325.9 | 4637.9 | 6193.7 | 5581.7 |
| الدخل المتاح للمشترك بما في ذلك الإضافي. العناصر | 2737.6 | -204.1 | 3232 | 8318.4 | 6193.7 | 5581.7 |
| صافي الدخل المخفف | 2737.6 | -204.1 | 3232 | 8318.4 | 6193.7 | 5581.7 |
| المتوسط المرجح المخفف للأسهم | 1061.82 | 1052.02 | 1033.67 | 935.684 | 912.505 | 911.681 |
| عائد السهم المخفف باستثناء العناصر غير العادية | 2.5782 | 4.27139 | 3.21757 | 4.95669 | 6.78758 | 6.12243 |
| Dividends per Share - Common Stock Primary Issue | 2.04 | 2.08 | 2.25 | 2.58 | 2.96 | 3.4 |
| الأرباح العادية المخففة للسهم الواحد | 2.89874 | 6.15171 | 5.37021 | 5.70063 | 7.63447 | 7.79951 |
| مجموع البنود الاستثنائية | -4697.7 | -93.9 | 3680.5 | 0 | 0 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| إجمالي الإيرادات | 6805.6 | 6740.1 | 6772.8 | 7999.9 | 7810 |
| عائد | 6805.6 | 6740.1 | 6772.8 | 7999.9 | 7810 |
| تكلفة الإيرادات، الإجمالي | 1878.6 | 1953.2 | 1430.8 | 2050.2 | 2072.1 |
| إجمالي الربح | 4927 | 4786.9 | 5342 | 5949.7 | 5737.9 |
| جمالي المصاريف التشغيلية | 5650.3 | 5336.7 | 5296.8 | 6082.7 | 5405.7 |
| مصاريف البيع/النفقات العامة/الإدارية، المجموع | 1576 | 1685.7 | 1577.9 | 1592 | 1557.9 |
| البحث والتطوير | 1684.8 | 1672.8 | 1708.9 | 1959.4 | 1610.1 |
| مصاريف غير اعتيادية (دخل) | 510.9 | 25 | 579.2 | 481.1 | 165.6 |
| الدخل التشغيلي | 1155.3 | 1403.4 | 1476 | 1917.2 | 2404.3 |
| إيرادات الفوائد (المصروفات)، صافي الإيرادات غير التشغيلية | 219.2 | 133.9 | -323.4 | -167.2 | -503.3 |
| اخرى, صافي | 101.9 | 56.6 | 92.7 | 89.9 | 152.6 |
| صافي الدخل قبل الضرائب | 1476.4 | 1593.9 | 1245.3 | 1839.9 | 2053.6 |
| صافي الدخل بعد الضرائب | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
| صافي الدخل قبل الإضافات. العناصر | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
| صافي الدخل | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
| الدخل المتاح للمشترك باستثناء الإضافات. العناصر | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
| الدخل المتاح للمشترك بما في ذلك الإضافي. العناصر | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
| صافي الدخل المخفف | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
| المتوسط المرجح المخفف للأسهم | 912.4 | 910.4 | 910.8 | 911.624 | 906.4 |
| عائد السهم المخفف باستثناء العناصر غير العادية | 1.48542 | 1.52702 | 1.21882 | 1.89343 | 2.0994 |
| Dividends per Share - Common Stock Primary Issue | 0.85 | 0.85 | 0.85 | 0.85 | 0.98 |
| الأرباح العادية المخففة للسهم الواحد | 2.02635 | 1.55448 | 1.80644 | 2.41408 | 2.28211 |
| مجموع البنود الاستثنائية | 0 |
- سنوي
- فصلية
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| إجمالي الأصول المتداولة | 15101.4 | 19202.1 | 20549.6 | 13709.6 | 17462.1 | 18452.4 |
| النقد والاستثمارات قصيرة الأجل | 6038.6 | 8034.1 | 7408.9 | 2438.5 | 3681.3 | 3908.6 |
| النقد وما يعادله | 4582.1 | 6536.2 | 7320.7 | 2337.5 | 3657.1 | 3818.5 |
| استثمارات قصيرة الأجل | 1456.5 | 1497.9 | 88.2 | 101 | 24.2 | 90.1 |
| مجموع المستحقات، صافي | 4766.3 | 5262.2 | 5776.8 | 5541.5 | 6929 | 8127.2 |
| Accounts Receivable - Trade, Net | 4029.4 | 4546.3 | 5776.8 | 4547.3 | 5875.3 | 6672.8 |
| Total Inventory | 3561.9 | 4458.3 | 3098.1 | 3190.7 | 3980.3 | 3886 |
| Prepaid Expenses | 734.6 | 1447.5 | 2036.7 | 2538.9 | 2871.5 | 2530.6 |
| Total Assets | 38805.9 | 44981 | 43908.4 | 39286.1 | 46633.1 | 48806 |
| Property/Plant/Equipment, Total - Net | 8252.6 | 8826.5 | 7996.1 | 8405 | 8681.9 | 8985.1 |
| Property/Plant/Equipment, Total - Gross | 16777.6 | 18091.1 | 16663 | 17566.6 | 18252.6 | 18961.8 |
| Accumulated Depreciation, Total | -8525 | -9264.6 | -8666.9 | -9161.6 | -9570.7 | -9976.7 |
| Goodwill, Net | 3972.7 | 4370.1 | 1366.6 | 3679.4 | 3766.5 | 3892 |
| Intangibles, Net | 4357.9 | 4029.2 | 1068 | 6618 | 7450 | 7691.9 |
| Long Term Investments | 5207.5 | 5678.8 | 2005.4 | 1962.4 | 2966.8 | 3212.6 |
| Other Long Term Assets, Total | 1913.8 | 2874.3 | 10922.7 | 4911.7 | 6305.8 | 6572 |
| Total Current Liabilities | 10986.6 | 14535.9 | 11888.1 | 11775.2 | 12481.6 | 15052.7 |
| Accounts Payable | 1349.3 | 1410.7 | 1207.1 | 1405.3 | 1606.7 | 1670.6 |
| Accrued Expenses | 896.9 | 997.9 | 955.6 | 915.5 | 997.2 | 958.1 |
| Notes Payable/Short Term Debt | 1299.3 | 2696.8 | 498.9 | 1494.2 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 638.1 | 1009.8 | 603.3 | 5.1 | 8.7 | 1538.3 |
| Other Current Liabilities, Total | 6803 | 8420.7 | 8623.2 | 7955.1 | 9869 | 10885.7 |
| Total Liabilities | 24798.2 | 33388.8 | 34079.7 | 36679.2 | 40991.5 | 39826.8 |
| Total Long Term Debt | 8367.8 | 9940.5 | 9196.4 | 13817.9 | 16586.6 | 15346.4 |
| Long Term Debt | 8358.8 | 9931.8 | 9196.4 | 13817.9 | 16586.6 | 15346.4 |
| Capital Lease Obligations | 9 | 8.7 | ||||
| Minority Interest | 72.8 | 75.7 | 1080.4 | 92.2 | 183.6 | 175.6 |
| Other Liabilities, Total | 5371 | 8836.7 | 10602.1 | 8806.4 | 9639.8 | 7518.4 |
| Total Equity | 14007.7 | 11592.2 | 9828.7 | 2606.9 | 5641.6 | 8979.2 |
| Common Stock | 688.5 | 687.9 | 661 | 598.8 | 598.2 | 596.3 |
| Additional Paid-In Capital | 5640.6 | 5817.8 | 6583.6 | 6685.3 | 6778.5 | 6833.4 |
| Retained Earnings (Accumulated Deficit) | 16046.3 | 13894.1 | 11395.9 | 4920.4 | 7830.2 | 8958.5 |
| Treasury Stock - Common | -80.5 | -75.8 | -69.4 | -60.8 | -55.7 | -52.7 |
| Unrealized Gain (Loss) | 224 | 113.5 | 4.9 | 14.8 | 3.7 | |
| Other Equity, Total | -8511.2 | -8845.3 | -8742.4 | -9541.7 | -9524.4 | -7360 |
| Total Liabilities & Shareholders’ Equity | 38805.9 | 44981 | 43908.4 | 39286.1 | 46633.1 | 48806 |
| Total Common Shares Outstanding | 1100.88 | 1100.01 | 1057.64 | 957.526 | 956.59 | 953.653 |
| Other Current Assets, Total | 2229.1 | 0 | ||||
| Deferred Income Tax | 1312.7 | 2187.5 | 2099.9 | 1733.7 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| إجمالي الأصول المتداولة | 16604.5 | 17295.5 | 17808.3 | 18452.4 | 16964.7 |
| النقد والاستثمارات قصيرة الأجل | 3051.4 | 3271.2 | 3825.3 | 3908.6 | 2568.3 |
| النقد وما يعادله | 3002.4 | 3220 | 3788.2 | 3818.5 | 2459.2 |
| استثمارات قصيرة الأجل | 49 | 51.2 | 37.1 | 90.1 | 109.1 |
| مجموع المستحقات، صافي | 6658.6 | 6902.8 | 7025 | 8127.2 | 7805.7 |
| Accounts Receivable - Trade, Net | 5592.8 | 5829.4 | 5914.3 | 6672.8 | 6322.5 |
| Total Inventory | 3660.8 | 3824.9 | 3907.4 | 3886 | 3893 |
| Prepaid Expenses | 3233.7 | 3296.6 | 3050.6 | 2530.6 | 2697.7 |
| Total Assets | 46838.3 | 47809 | 48187 | 48806 | 46919.3 |
| Property/Plant/Equipment, Total - Net | 8630.1 | 8855.5 | 8920.4 | 8985.1 | 9102.7 |
| Property/Plant/Equipment, Total - Gross | 18273.5 | 18697.7 | 18883.2 | 18961.8 | 19241 |
| Accumulated Depreciation, Total | -9643.4 | -9842.2 | -9962.8 | -9976.7 | -10138.3 |
| Goodwill, Net | 3877.4 | 3884.2 | 3884.1 | 3892 | 3892 |
| Intangibles, Net | 8087.8 | 7985.4 | 7887.7 | 7691.9 | 7482.4 |
| Long Term Investments | 3232.4 | 3474.9 | 3350.5 | 3212.6 | 2727.3 |
| Other Long Term Assets, Total | 6406.1 | 6313.5 | 6336 | 6572 | 6750.2 |
| Total Current Liabilities | 11714.2 | 15093.2 | 13682 | 15052.7 | 13386 |
| Accounts Payable | 1639.6 | 1597.8 | 1566.8 | 1670.6 | 1433.3 |
| Accrued Expenses | 649.9 | 755.5 | 836.6 | 958.1 | 693.1 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 4.9 | 1778.5 | 1563 | 1538.3 | 1355.9 |
| Other Current Liabilities, Total | 9419.8 | 10961.4 | 9715.6 | 10885.7 | 9903.7 |
| Total Liabilities | 39939.6 | 41364.6 | 40430 | 39826.8 | 37588.5 |
| Total Long Term Debt | 16199.6 | 14736.6 | 15522.4 | 15346.4 | 15152.9 |
| Long Term Debt | 16199.6 | 14736.6 | 15522.4 | 15346.4 | 15152.9 |
| Deferred Income Tax | 2200.6 | 1857.3 | 1632.5 | 1733.7 | 1286.1 |
| Minority Interest | 200.6 | 219.1 | 197.1 | 175.6 | 131.2 |
| Other Liabilities, Total | 9624.6 | 9458.4 | 9396 | 7518.4 | 7632.3 |
| Total Equity | 6898.7 | 6444.4 | 7757 | 8979.2 | 9330.8 |
| Common Stock | 599.7 | 598.1 | 598.2 | 596.3 | 594.1 |
| Additional Paid-In Capital | 6579.2 | 6669.2 | 6758 | 6833.4 | 6656.3 |
| Retained Earnings (Accumulated Deficit) | 9181.3 | 8530.1 | 9639.4 | 8958.5 | 9369.4 |
| Treasury Stock - Common | -52.7 | -52.7 | -52.7 | -52.7 | -50.5 |
| Unrealized Gain (Loss) | 4.5 | 9.1 | 6.8 | 3.7 | -18.1 |
| Other Equity, Total | -9413.3 | -9309.4 | -9192.7 | -7360 | -7220.4 |
| Total Liabilities & Shareholders’ Equity | 46838.3 | 47809 | 48187 | 48806 | 46919.3 |
| Total Common Shares Outstanding | 959.019 | 956.575 | 956.589 | 953.653 | 950.155 |
- سنوي
- فصلية
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Net income/Starting Line | 2737.6 | -204.1 | 3232 | 8318.4 | 6193.7 | 5581.7 |
| Cash From Operating Activities | 4851 | 5615.6 | 5524.5 | 4836.6 | 6499.6 | 7260.7 |
| Cash From Operating Activities | 1496.6 | 1567.3 | 1609 | 1232.6 | 1323.9 | 1547.6 |
| Deferred Taxes | 439.5 | -787.9 | 326.8 | 62.4 | -134.5 | -802.3 |
| Non-Cash Items | 661.4 | 1835.4 | 2735.4 | -3089.6 | -136.1 | 1956.3 |
| Cash Taxes Paid | 700.6 | 246.5 | 1101.5 | 1180.5 | 954.6 | 1598.8 |
| Cash Interest Paid | 146.4 | 192.7 | 223.8 | 305.5 | 345.8 | 338 |
| Changes in Working Capital | -484.1 | 3204.9 | -2378.7 | -1687.2 | -747.4 | -1022.6 |
| Cash From Investing Activities | -3139.1 | -3783.6 | 1906 | -8082.9 | -2258.9 | -2762.3 |
| Capital Expenditures | -1092 | -2163.6 | -3018.2 | -1353.5 | -2029.1 | -1873.2 |
| Other Investing Cash Flow Items, Total | -2047.1 | -1620 | 4924.2 | -6729.4 | -229.8 | -889.1 |
| Cash From Financing Activities | -559.8 | 142.6 | -5904.9 | -2324.5 | -3137.1 | -4131.3 |
| Financing Cash Flow Items | -300.8 | -364.4 | -372.8 | -200.1 | -241.6 | -295.9 |
| Total Cash Dividends Paid | -2158.5 | -2192.1 | -2311.8 | -2409.8 | -2687.1 | -3086.8 |
| Issuance (Retirement) of Stock, Net | -600.1 | -299.8 | -2491 | -4400 | -500 | -1250 |
| Issuance (Retirement) of Debt, Net | 2499.6 | 2998.9 | -729.3 | 4685.4 | 291.6 | 501.4 |
| Foreign Exchange Effects | -236.4 | -20.5 | -63.6 | -89.9 | 216 | -205.7 |
| Net Change in Cash | 915.7 | 1954.1 | 1462 | -5660.7 | 1319.6 | 161.4 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 1355.3 | 2745.5 | 3855.6 | 5581.7 | 1902.9 |
| Cash From Operating Activities | 1697.4 | 3472.9 | 5104.2 | 7260.7 | 2499.2 |
| Cash From Operating Activities | 350.3 | 719.6 | 1101.9 | 1547.6 | 435.7 |
| Deferred Taxes | -119.1 | -413.8 | -709.8 | -802.3 | -506.6 |
| Non-Cash Items | 213.7 | 303.2 | 1404.6 | 1956.3 | 712.7 |
| Changes in Working Capital | -102.8 | 118.4 | -548.1 | -1022.6 | -45.5 |
| Cash From Investing Activities | -1283.5 | -1766.8 | -2383.3 | -2762.3 | -1013.8 |
| Capital Expenditures | -492.1 | -1023.4 | -1479 | -1873.2 | -857.2 |
| Other Investing Cash Flow Items, Total | -791.4 | -743.4 | -904.3 | -889.1 | -156.6 |
| Cash From Financing Activities | -1058.4 | -2141.6 | -2604.8 | -4131.3 | -2878.3 |
| Financing Cash Flow Items | -279.9 | -294.8 | -295.3 | -295.9 | -282.4 |
| Total Cash Dividends Paid | -774.8 | -1543.1 | -2313.5 | -3086.8 | -885.5 |
| Issuance (Retirement) of Stock, Net | 0 | -500 | -500 | -1250 | -1500 |
| Issuance (Retirement) of Debt, Net | -3.7 | 196.3 | 504 | 501.4 | -210.4 |
| Foreign Exchange Effects | -10.2 | -1.6 | 15 | -205.7 | 33.6 |
| Net Change in Cash | -654.7 | -437.1 | 131.1 | 161.4 | -1359.3 |
| اسم المستثمر | نوع المستثمر | النسبة المئوية المستحقة | الاسهم المملوكة | تغيير الأسهم المملوكة | تاريخ الإمتلاك | معدل العائدات |
|---|---|---|---|---|---|---|
| Lilly Endowment, Inc. | Investment Advisor | 10.8347 | 102948810 | -210000 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.6008 | 72221213 | 994066 | 2022-09-30 | LOW |
| PNC Wealth Management | Investment Advisor | 5.4451 | 51738161 | -44061 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.2364 | 40253792 | 58949 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.5343 | 33582472 | 168444 | 2022-09-30 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 3.3604 | 31929656 | 631015 | 2022-09-30 | LOW |
| Capital World Investors | Investment Advisor | 3.0547 | 29024874 | 282228 | 2022-09-30 | LOW |
| PRIMECAP Management Company | Investment Advisor | 2.9486 | 28017155 | -421333 | 2022-09-30 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 2.5054 | 23805927 | 3379269 | 2022-09-30 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.2989 | 21843288 | -1593968 | 2022-09-30 | LOW |
| State Farm Insurance Companies | Insurance Company | 1.8324 | 17410725 | 0 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.6935 | 16091249 | 373938 | 2022-09-30 | LOW |
| Jennison Associates LLC | Investment Advisor/Hedge Fund | 1.0592 | 10064742 | -293324 | 2022-09-30 | LOW |
| JP Morgan Asset Management | Investment Advisor | 0.866 | 8228610 | 173535 | 2022-09-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8435 | 8014500 | -246196 | 2021-12-31 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7439 | 7068030 | -132558 | 2022-09-30 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.6244 | 5933104 | -307204 | 2022-09-30 | LOW |
| Capital International Investors | Investment Advisor | 0.5893 | 5599174 | 637189 | 2022-09-30 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.5885 | 5591703 | -216451 | 2022-09-30 | LOW |
| BofA Global Research (US) | Research Firm | 0.5868 | 5576096 | -144521 | 2022-09-30 | LOW |
لماذا Capital.com هي اختيارك الأمثل؟ الأمر بسيط ! انظر إلى الأرقام وقرر بنفسك.
Capital.com Group +485000+
عدد المتداولين
65000+
عدد المتداولين النشطين شهريا
$48000000+
حجم الاستثمار شهريا
$28000000+
جرّب الآن عمليات السحب شهريا
حاسبة التداول
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
عمولة التداول
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
الرافعة المالية
20:1
- 20
- 100
- 500
- 1000
- 10000
الاستثمار
حجم الصفقة (الرافعة المالية × الاستثمار):
الفتح
الإغلاق
بيع على المكشوف شراء
| Industry: | Pharmaceuticals (NEC) |
Lilly Corporate Ctr
Drop Code 1094
INDIANAPOLIS
INDIANA 46285-0001
US
بيان الدخل
- Annual
- Quarterly
الناس ايضا يتابعون
هل ما زلت تبحث عن وسيط يمكنك أن تثق فيه؟
انضم إلى أكثر من 485،000متداول من جميع أنحاء العالم اختاروا التداول مع Capital.com